Want to see AVTR full AI Analyst Report?
AVTR Stock Chart & Stats
$8.52
-$0.18(-0.80%)
At close: 4:00 PM EST
$8.52
-$0.18(-0.80%)
Day’s Range― - ―
52-Week Range$7.27 - $15.93
Previous CloseN/A
Volume664.76K
Average Volume (3M)10.06M
Market Cap
$7.05B
Enterprise Value$10.00B
Total Cash (Recent Filing)$279.30M
Total Debt (Recent Filing)$3.82B
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Jul 29, 2026EPS Estimate
0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.80
Shares Outstanding682,755,430
10 Day Avg. Volume9,142,205
30 Day Avg. Volume10,061,766
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.40
Price to Sales (P/S)1.19
P/FCF Ratio15.70
Enterprise Value/Market Cap1.42
Enterprise Value/Revenue1.53
Enterprise Value/Gross Profit4.75
Enterprise Value/Ebitda78.77
Forecast
1Y Price Target
$8.78Price Target Upside3.03% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)0.79
Revenue Forecast (FY)$6.50B
Bulls Say, Bears Say
Bulls Say
Cash Generation ResilienceSustained positive operating and free cash flow despite accounting losses shows the business converts recurring consumables and services into real cash. That cash supports debt paydown, prioritized capex and the Revival program investments, giving the company runway to execute strategic fixes over the next several quarters without urgent external financing.
Improved Balance Sheet LeverageMaterial reduction in leverage materially improves financial flexibility and lowers refinancing and interest risk. A less debt-heavy capital structure increases capacity to fund targeted automation, transformation projects and M&A while reducing vulnerability to macro shocks, supporting durability of operations over a multi-quarter recovery period.
BMP Demand And Margin StrengthHigh BMP margins, improving order book and easing backorders indicate durable demand in process chemicals and specialized materials. Strong book-to-bill and segment profitability provide a steadier earnings base and cash conversion that can offset distribution softness, making enterprise recovery more achievable if BMP trends sustain into H2 and beyond.
Bears Say
Revenue And Profit DeteriorationA pronounced decline in top-line scale and transition to net losses erodes operating leverage and the firm's ability to cover fixed costs. If organic revenue contraction persists, it will impair margin recovery, reduce reinvestment capacity and make hitting cash flow targets harder, keeping execution and return-to-growth dependent on sustained structural improvements.
Margin Pressure From Inflation And MixOngoing raw-material, freight and geopolitically driven inflation compresses gross and operating margins on a recurring basis unless fully passed to customers. Given competitive distribution markets and mix shifts, such headwinds can persist across quarters, reducing the pace of margin recovery and pressuring free cash flow if not offset by efficiency or price actions.
Finance Leadership TransitionA CFO departure during an active turnaround and deleveraging plan raises execution and reporting risk. Even with an experienced interim, leadership transitions can slow financial strategy, capital allocation and lender communication, potentially affecting timing of debt reduction targets and investor confidence across the multi-quarter Revival execution period.
Avantor News
AVTR FAQ
What was Avantor’s price range in the past 12 months?
Avantor lowest stock price was $7.26 and its highest was $15.93 in the past 12 months.
What is Avantor’s market cap?
Avantor’s market cap is $7.05B.
When is Avantor’s upcoming earnings report date?
Avantor’s upcoming earnings report date is Jul 29, 2026 which is in 22 days.
How were Avantor’s earnings last quarter?
Avantor released its earnings results on Apr 29, 2026. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.157 by $0.013.
Is Avantor overvalued?
According to Wall Street analysts Avantor’s price is currently Undervalued.
Does Avantor pay dividends?
Avantor does not currently pay dividends.
What is Avantor’s EPS estimate?
Avantor’s EPS estimate is 0.19.
How many shares outstanding does Avantor have?
Avantor has 682,755,430 shares outstanding.
What happened to Avantor’s price movement after its last earnings report?
Avantor reported an EPS of $0.17 in its last earnings report, beating expectations of $0.157. Following the earnings report the stock price went down -0.127%.
Which hedge fund is a major shareholder of Avantor?
Currently, no hedge funds are holding shares in AVTR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Avantor Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.78 (3.03% Upside)
$8.78 (3.03% Upside)
Blogger Sentiment
Neutral
AVTR Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 17.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $286.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.70%
12-Months-Change
Fundamentals
Return on Equity
-9.59%
Trailing 12-Months
Asset Growth
-5.38%
Trailing 12-Months
Company Description
Avantor
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
AVTR Company Deck
AVTR Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: clear operational progress from the Revival program (leadership refresh, digital and kaizen-driven efficiency projects, improved BMP order trends and e-commerce gains) and a Q1 outperformance on EPS versus expectations. However, meaningful near-term revenue declines, margin pressure from mix and freight, customer prebates depressing early cash flow, geopolitical inflationary risk ($10–$20M headwind) and a CFO transition temper the outlook. Management reaffirmed guidance and expects stabilization in H1 with a path to organic growth in H2, but execution and macro risks will determine whether that recovery materializes.View all AVTR earnings summariesAVTR Net sales Breakdown
58.44% Americas
34.74% Europe
6.82% AMEA
AVTR Stock 12 Month Forecast
Average Price Target
$8.78
▲(3.03% Upside)
Technical Analysis
Albemarle
―
Eastman Chemical
―
Quaker Chemical
―
Sociedad Quimica Y Minera SA
―
Westlake Corporation
―
Ownership Overview
0.95% Insiders
41.30% Mutual Funds
34.78% Other Institutional Investors
5.02% Public Companies and
Individual Investors